Solve Your Your Legal Issues, now offering Affordable and Flat Fee Pricing options
Solve Your Your Legal Issues, now offering Affordable and Flat Fee Pricing options
The U.S. House Judiciary IP Subcommittee to hold a hearing on patents, drug prices, and affordability, the week of June 2, 2026.
Watch the hearing and download witness testimony here:
https://judiciary.house.gov/schedule
SCOTUSBlog coverage
Supreme Court Oral Argument Transcript
https://www.supremecourt.gov/oral_arguments/argument_transcripts/2025/24-889_2024.pdf
Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
https://www.cafc.uscourts.gov/opinions-orders/24-1641.OPINION.5-13-2026_2693032.pdf "
###
"XXXX"
Nonprofit Drug Companies: Information on Funding, Drug Types, Challenges, and Reported Effect
GAO-25-107153
Published: May 01, 2025. Publicly Released: May 01, 2025.
The Senate Subcommittee on Intellectual Property held a key hearing regarding the Patent Eligibility Restoration Act (PERA) on October 8, 2025.
The U.S. Congress is pursuing legislation to fight unauthorized Gen AI digital replicas. It's called the "NO FAKES Act." More below.
U.S. Senate Press release
https://www.google.com/search?client=safari&rls=en&q=blackburn+no+fakes&ie=UTF-8&oe=UTF-8
Updated Bill Text
https://www.blackburn.senate.gov/services/files/7B628752-82C4-4FC6-89DC-94345BC06540